Produkty lecznicze - Wykaz pozwoleń na dopuszczenie do obrotu udzielonych przez państwa EFTA należące do EOG w pierwszym półroczu 2015 r.
Dz.U.UE.C.2016.347.4
Akt nienormatywnyProdukty lecznicze - Wykaz pozwoleń na dopuszczenie do obrotu udzielonych przez państwa EFTA należące do EOG w pierwszym półroczu 2015 r.
(Dz.U.UE C z dnia 22 września 2016 r.)
Podkomitet I ds. Swobodnego Przepływu Towarów
Do wiadomości Wspólnego Komitetu EOG
W nawiązaniu do decyzji Wspólnego Komitetu EOG nr 74/1999 z dnia 28 maja 1999 r. Wspólnemu Komitetowi EOG przekazuje się celem przyjęcia do wiadomości na posiedzeniu w dniu 29 kwietnia 2016 r. następujące wykazy dotyczące pozwoleń na dopuszczenie do obrotu produktów leczniczych za okres od dnia 1 stycznia do dnia 30 czerwca 2015 r.:
Załącznik I Wykaz nowych pozwoleń na dopuszczenie do obrotu
Załącznik II Wykaz odnowionych pozwoleń na dopuszczenie do obrotu
Załącznik III Wykaz przedłużonych pozwoleń na dopuszczenie do obrotu
Załącznik IV Wykaz wycofanych pozwoleń na dopuszczenie do obrotu
Załącznik V Wykaz zawieszonych pozwoleń na dopuszczenie do obrotu
ZAŁĄCZNIKI
ZAŁĄCZNIK I
Wykaz nowych pozwoleń na dopuszczenie do obrotu
Wykaz nowych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data udzielenia zezwolenia |
EU/1/07/423 | Vectibix | Liechtenstein | 28.2.2015 |
EU/1/11/709 | Buccolam | Liechtenstein | 28.2.2015 |
EU/1/11/721 | Paglitaz | Liechtenstein | 28.2.2015 |
EU/1/11/745 | Desloratadine Actavis | Liechtenstein | 28.2.2015 |
EU/1/12/755 | Pioglitazone Actavis | Liechtenstein | 28.2.2015 |
EU/1/12/757 | Pioglitazone Teva | Liechtenstein | 28.2.2015 |
EU/1/12/758 | Pioglitazone Teva Pharma | Liechtenstein | 28.2.2015 |
EU/1/12/760 | Bronchitol | Liechtenstein | 28.2.2015 |
EU/1/12/811 | Lyxumia | Liechtenstein | 28.2.2015 |
EU/1/13/817 | Actelsar HCT | Liechtenstein | 28.2.2015 |
EU/1/13/822 | PHEBURANE | Liechtenstein | 28.2.2015 |
EU/1/13/830 | Stribild | Liechtenstein | 28.2.2015 |
EU/1/13/835 | Voriconazole Accord | Liechtenstein | 28.2.2015 |
EU/1/13/845 | Imatinib Accord | Liechtenstein | 28.2.2015 |
EU/1/13/846 | Xtandi | Liechtenstein | 28.2.2015 |
EU/1/13/859 | Levodopa-Carbidopa-Entacapone Sandoz | Liechtenstein | 28.2.2015 |
EU/1/13/879 | Giotrif | Liechtenstein | 28.2.2015 |
EU/1/13/893 | Opsumit | Liechtenstein | 28.2.2015 |
EU/1/14/932 | Vantobra | Islandia | 17.4.2015 |
EU/1/14/932 | Vantobra | Norwegia | 15.4.2015 |
EU/1/14/936 | Nuwiq | Liechtenstein | 28.2.2015 |
EU/1/14/952 | Sevelamer carbonate Zentiva | Islandia | 6.2.2015 |
EU/1/14/952 | Sevelamer carbonate Zentiva | Liechtenstein | 28.2.2015 |
EU/1/14/952 | Sevelamer carbonate Zentiva | Norwegia | 06.2.2015 |
EU/1/14/953 | Tasermity | Islandia | 12.3.2015 |
EU/1/14/953 | Tasermity | Liechtenstein | 28.2.2015 |
EU/1/14/953 | Tasermity | Norwegia | 12.3.2015 |
EU/1/14/957 | Cyramza | Islandia | 15.1.2015 |
EU/1/14/957 | Cyramza | Liechtenstein | 28.2.2015 |
EU/1/14/957 | Cyramza | Norwegia | 13.1.2015 |
EU/1/14/959 | Lynparza | Islandia | 14.1.2015 |
EU/1/14/959 | Lynparza | Norwegia | 12.1.2015 |
EU/1/14/960 | DUAVIVE | Islandia | 14.1.2015 |
EU/1/14/960 | Duavive | Norwegia | 12.1.2015 |
EU/1/14/969 | SCENESSE | Islandia | 15.1.2015 |
EU/1/14/969 | Scenesse | Norwegia | 15.1.2015 |
EU/1/14/970 | RIXUBIS | Islandia | 14.1.2015 |
EU/1/14/970 | Rixubis | Norwegia | 13.1.2015 |
EU/1/14/972 | Duloxetine Lilly | Islandia | 6.1.2015 |
EU/1/14/973 | Quinsair | Islandia | 19.4.2015 |
EU/1/14/973 | Quinsair | Liechtenstein | 30.4.2015 |
EU/1/14/973 | Quinsair | Norwegia | 15.4.2015 |
EU/1/14/974 | Cerdelga | Islandia | 5.2.2015 |
EU/1/14/974 | Cerdelga | Liechtenstein | 28.2.2015 |
EU/1/14/974 | Cerdelga | Norwegia | 10.2.2015 |
EU/1/14/975 | Clopidogrel ratiopharm | Liechtenstein | 28.2.2015 |
EU/1/14/975 | Clopidogrel ratiopharm | Norwegia | 5.3.2015 |
EU/1/14/975 | Clopidogrel ratiopharm | Islandia | 11.3.2015 |
EU/1/14/976 | Zontivity | Islandia | 5.2.2015 |
EU/1/14/976 | Zontivity | Liechtenstein | 28.2.2015 |
EU/1/14/976 | Zontivity | Norwegia | 16.2.2015 |
EU/1/14/977 | Rasagilin ratiopharm | Liechtenstein | 28.2.2015 |
EU/1/14/977 | Rasagiline ratiopharm | Islandia | 22.1.2015 |
EU/1/14/977 | Rasagiline ratiopharm | Norwegia | 09.2.2015 |
EU/1/14/978 | Senshio | Islandia | 30.1.2015 |
EU/1/14/978 | Senshio | Liechtenstein | 28.2.2015 |
EU/1/14/978 | Senshio | Norwegia | 16.2.2015 |
EU/1/14/979 | Ofev | Islandia | 30.1.2015 |
EU/1/14/979 | Ofev | Liechtenstein | 28.2.2015 |
EU/1/14/979 | Ofev | Norwegia | 29.1.2015 |
EU/1/14/980 | Cosentyx | Islandia | 4.2.2015 |
EU/1/14/980 | Cosentyx | Liechtenstein | 28.2.2015 |
EU/1/14/980 | Cosentyx | Norwegia | 30.1.2015 |
EU/1/14/981 | Otezla | Islandia | 5.2.2015 |
EU/1/14/981 | Otezla | Liechtenstein | 28.2.2015 |
EU/1/14/981 | Otezla | Norwegia | 30.1.2015 |
EU/1/14/982 | Viekirax | Islandia | 29.1.2015 |
EU/1/14/982 | Viekirax | Liechtenstein | 28.2.2015 |
EU/1/14/982 | Viekirax | Norwegia | 20.1.2015 |
EU/1/14/983 | Exviera | Islandia | 29.1.2015 |
EU/1/14/983 | Exviera | Liechtenstein | 28.2.2015 |
EU/1/14/983 | Exviera | Norwegia | 20.1.2015 |
EU/1/14/984 | Xadago | Islandia | 11.3.2015 |
EU/1/14/984 | Xadago | Liechtenstein | 28.2.2015 |
EU/1/14/984 | Xadago | Norwegia | 16.3.2015 |
EU/1/14/985 | Raplixa | Islandia | 17.4.2015 |
EU/1/14/985 | Raplixa | Liechtenstein | 30.4.2015 |
EU/1/14/985 | Raplixa | Norwegia | 10.4.2015 |
EU/1/14/986 | Xydalba | Islandia | 11.3.2015 |
EU/1/14/986 | Xydalba | Liechtenstein | 28.2.2015 |
EU/1/14/986 | Xydalba | Norwegia | 2.3.2015 |
EU/1/14/987 | Holoclar | Islandia | 11.3.2015 |
EU/1/14/987 | Holoclar | Liechtenstein | 28.2.2015 |
EU/1/14/987 | Holoclar | Norwegia | 26.2.2015 |
EU/1/14/988 | Mysimba | Islandia | 19.4.2015 |
EU/1/14/988 | Mysimba | Liechtenstein | 30.4.2015 |
EU/1/14/988 | Mysimba | Norwegia | 15.4.2015 |
EU/1/15/1000 | Jinarc | Islandia | 4.6.2015 |
EU/1/15/1000 | Jinarc | Liechtenstein | 30.6.2015 |
EU/1/15/1000 | Jinarc | Norwegia | 12.6.2015 |
EU/1/15/1001 | Akynzeo | Islandia | 4.6.2015 |
EU/1/15/1001 | Akynzeo | Liechtenstein | 30.6.2015 |
EU/1/15/1001 | Akynzeo | Norwegia | 5.6.2015 |
EU/1/15/1002 | Lenvima | Islandia | 15.6.2015 |
EU/1/15/1002 | Lenvima | Liechtenstein | 30.6.2015 |
EU/1/15/1002 | Lenvima | Norwegia | 15.6.2015 |
EU/1/15/1003 | Synjardy | Islandia | 9.6.2015 |
EU/1/15/1003 | Synjardy | Liechtenstein | 30.6.2015 |
EU/1/15/1003 | Synjardy | Norwegia | 17.6.2015 |
EU/1/15/1004 | Voriconazol Hospira | Liechtenstein | 30.6.2015 |
EU/1/15/1004 | Voriconazole Hospira | Islandia | 4.6.2015 |
EU/1/15/1004 | Voriconazole Hospira | Norwegia | 18.6.2015 |
EU/1/15/1007 | Gardasil 9 | Liechtenstein | 30.6.2015 |
EU/1/15/1007 | Gardasil 9 | Norwegia | 18.6.2015 |
EU/1/15/1009 | Aripiprazole Zentiva | Liechtenstein | 30.6.2015 |
EU/1/15/1010 | Duloxetine Mylan | Liechtenstein | 30.6.2015 |
EU/1/15/1011 | Pregabalin Sandoz | Liechtenstein | 30.6.2015 |
EU/1/15/1012 | Pregabalin Sandoz GmbH | Liechtenstein | 30.6.2015 |
EU/1/15/1013 | Lumark | Liechtenstein | 30.6.2015 |
EU/1/15/1014 | Opdivo | Liechtenstein | 30.6.2015 |
EU/1/15/989 | Orbactiv | Islandia | 17.4.2015 |
EU/1/15/989 | Orbactiv | Liechtenstein | 30.4.2015 |
EU/1/15/989 | Orbactiv | Norwegia | 15.4.2015 |
EU/1/15/990 | Ikervis | Islandia | 17.4.2015 |
EU/1/15/990 | IKERVIS | Liechtenstein | 30.4.2015 |
EU/1/15/990 | IKERVIS | Norwegia | 9.4.2015 |
EU/1/15/991 | Sivextro | Islandia | 19.4.2015 |
EU/1/15/991 | Sivextro | Liechtenstein | 30.4.2015 |
EU/1/15/991 | Sivextro | Norwegia | 15.4.2015 |
EU/1/15/992 | Saxenda | Islandia | 19.4.2015 |
EU/1/15/992 | Saxenda | Liechtenstein | 30.4.2015 |
EU/1/15/992 | Saxenda | Norwegia | 9.4.2015 |
EU/1/15/993 | Lixiana | Liechtenstein | 30.6.2015 |
EU/1/15/994 | Kengrexal | Islandia | 19.4.2015 |
EU/1/15/994 | Kengrexal | Liechtenstein | 30.4.2015 |
EU/1/15/994 | Kengrexal | Norwegia | 10.4.2015 |
EU/1/15/995 | DUTREBIS | Islandia | 19.4.2015 |
EU/1/15/995 | DUTREBIS | Liechtenstein | 30.4.2015 |
EU/1/15/995 | DUTREBIS | Norwegia | 10.4.2015 |
EU/1/15/996 | Ristempa | Islandia | 11.5.2015 |
EU/1/15/996 | Ristempa | Liechtenstein | 30.4.2015 |
EU/1/15/996 | Ristempa | Norwegia | 13.4.2015 |
EU/1/15/999 | Zykadia | Islandia | 4.6.2015 |
EU/1/15/999 | Zykadia | Liechtenstein | 30.6.2015 |
EU/1/15/999 | Zykadia | Norwegia | 27.5.2015 |
EU/2/11/122 | BLUEVAC BTV8 | Liechtenstein | 28.2.2015 |
EU/2/11/131 | Zulvac 1 Ovis | Liechtenstein | 28.2.2015 |
EU/2/12/140 | Poulvac E. coli | Liechtenstein | 28.2.2015 |
EU/2/12/142 | Cardalis | Liechtenstein | 28.2.2015 |
EU/2/13/151 | Equilis West Nile | Liechtenstein | 28.2.2015 |
EU/2/13/152 | ProZinc | Liechtenstein | 28.2.2015 |
EU/2/14/162 | Parvoduk | Liechtenstein | 28.2.2015 |
EU/2/14/176 | Bovela | Islandia | 15.1.2015 |
EU/2/14/176 | Bovela | Norwegia | 23.1.2015 |
EU/2/14/177 | Nexgard Spectra | Islandia | 30.1.2015 |
EU/2/14/177 | NEXGARD SPECTRA | Liechtenstein | 28.2.2015 |
EU/2/14/177 | Nexgard Spectra | Norwegia | 13.2.2015 |
EU/2/14/178 | Zulvac SBV | Islandia | 24.2.2015 |
EU/2/14/178 | Zulvac SBV | Liechtenstein | 28.2.2015 |
EU/2/14/178 | Zulvac SBV | Norwegia | 11.3.2015 |
EU/2/14/179 | Suvaxyn CSF Marker | Islandia | 9.4.2015 |
EU/2/14/179 | Suvaxyn CSF Marker | Liechtenstein | 30.4.2015 |
EU/2/14/179 | Suvaxyn CSF Marker | Norwegia | 9.4.2015 |
EU/2/14/180 | Coliprotec F4 | Islandia | 15.4.2015 |
EU/2/14/180 | Coliprotec F4 | Liechtenstein | 30.4.2015 |
EU/2/14/180 | Coliprotec F4 | Norwegia | 9.4.2015 |
EU/2/15/181 | Sileo | Liechtenstein | 30.6.2015 |
EU/2/15/181 | Sileo | Norwegia | 30.6.2015 |
ZAŁĄCZNIK II
Wykaz odnowionych pozwoleń na dopuszczenie do obrotu
Wykaz odnowionych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data udzielenia zezwolenia |
EU/1/00/133 | Optisulin | Islandia | 18.3.2015 |
EU/1/00/133 | Optisulin | Liechtenstein | 28.2.2015 |
EU/1/00/133 | Optisulin | Norwegia | 27.2.2015 |
EU/1/00/134 | Lantus | Islandia | 17.3.2015 |
EU/1/00/134 | Lantus | Liechtenstein | 28.2.2015 |
EU/1/00/134 | Lantus | Norwegia | 5.3.2015 |
EU/1/05/308 | Aclasta | Islandia | 5.2.2015 |
EU/1/05/308 | Aclasta | Liechtenstein | 28.2.2015 |
EU/1/05/308 | Aclasta | Norwegia | 17.2.2015 |
EU/1/05/310 | Fosavance | Liechtenstein | 30.6.2015 |
EU/1/05/310 | Fosavance | Norwegia | 19.5.2015 |
EU/1/05/315 | APTIVUS | Liechtenstein | 30.6.2015 |
EU/1/05/319 | Xolair | Liechtenstein | 30.6.2015 |
EU/1/07/423 | Vectibix | Islandia | 15.1.2015 |
EU/1/07/423 | Vectibix | Norwegia | 29.1.2015 |
EU/1/08/506 | Celvapan | Islandia | 3.6.2015 |
EU/1/08/506 | Celvapan | Liechtenstein | 30.6.2015 |
EU/1/08/506 | Celvapan | Norwegia | 27.5.2015 |
EU/1/09/601 | Firdapse | Islandia | 18.2.2015 |
EU/1/09/610 | Telmisartan Teva | Islandia | 14.1.2015 |
EU/1/09/610 | Telmisartan Teva | Liechtenstein | 28.2.2015 |
EU/1/09/610 | Telmisartan Teva | Norwegia | 13.1.2015 |
EU/1/10/612 | Revolade | Islandia | 30.1.2015 |
EU/1/10/612 | Revolade | Liechtenstein | 28.2.2015 |
EU/1/10/612 | Revolade | Norwegia | 29.1.2015 |
EU/1/10/615 | Temozolomide Hospira | Islandia | 22.1.2015 |
EU/1/10/615 | Temozolomide Hospira | Liechtenstein | 28.2.2015 |
EU/1/10/615 | Temozolomide Hospira | Norwegia | 28.1.2015 |
EU/1/10/618 | Prolia | Islandia | 4.2.2015 |
EU/1/10/618 | Prolia | Liechtenstein | 28.2.2015 |
EU/1/10/618 | Prolia | Norwegia | 9.2.2015 |
EU/1/10/620 | Ristfor | Islandia | 14.1.2015 |
EU/1/10/620 | Ristfor | Norwegia | 13.1.2015 |
EU/1/10/621 | Ristaben | Islandia | 14.1.2015 |
EU/1/10/621 | Ristaben | Norwegia | 13.1.2015 |
EU/1/10/625 | Arzerra | Islandia | 2.3.2015 |
EU/1/10/625 | Arzerra | Liechtenstein | 28.2.2015 |
EU/1/10/625 | Arzerra | Norwegia | 26.2.2015 |
EU/1/10/627 | Raloxifene Teva | Islandia | 20.2.2015 |
EU/1/10/627 | Raloxifene Teva | Liechtenstein | 28.2.2015 |
EU/1/10/627 | Raloxifene Teva | Norwegia | 27.2.2015 |
EU/1/10/631 | Nivestim | Islandia | 15.6.2015 |
EU/1/10/631 | Nivestim | Liechtenstein | 30.6.2015 |
EU/1/10/631 | Nivestim | Norwegia | 18.6.2015 |
EU/1/10/632 | Tolura | Islandia | 17.4.2015 |
EU/1/10/632 | Tolura | Liechtenstein | 30.4.2015 |
EU/1/10/632 | Tolura | Norwegia | 9.4.2015 |
EU/1/10/633 | Topotecan Hospira | Islandia | 15.6.2015 |
EU/1/10/633 | Topotecan Hospira | Liechtenstein | 30.6.2015 |
EU/1/10/633 | Topotecan Hospira | Norwegia | 15.6.2015 |
EU/1/10/634 | Ribavirin Mylan | Liechtenstein | 28.2.2015 |
EU/1/10/634 | Ribavirin Mylan | Norwegia | 27.2.2015 |
EU/1/10/634 | Ribavirin Mylan | Islandia | 20.2.2015 |
EU/1/10/635 | Olanzapine Apotex | Liechtenstein | 28.2.2015 |
EU/1/10/635 | Olanzapine Apotex | Norwegia | 27.2.2015 |
EU/1/10/635 | Olanzapine Apotex | Islandia | 20.2.2015 |
EU/1/10/636 | Daxas | Islandia | 12.5.2015 |
EU/1/10/636 | Daxas | Norwegia | 15.5.2015 |
EU/1/10/637 | Leflunomid medac | Liechtenstein | 30.4.2015 |
EU/1/10/637 | Leflunomide medac | Islandia | 19.4.2015 |
EU/1/10/637 | Leflunomide medac | Norwegia | 9.4.2015 |
EU/1/10/638 | Ozurdex | Islandia | 19.4.2015 |
EU/1/10/638 | Ozurdex | Liechtenstein | 30.4.2015 |
EU/1/10/638 | Ozurdex | Norwegia | 9.4.2015 |
EU/1/10/639 | Telmisartan Actavis | Liechtenstein | 30.6.2015 |
EU/1/10/640 | Sycrest | Islandia | 1.6.2015 |
EU/1/10/640 | Sycrest | Liechtenstein | 30.6.2015 |
EU/1/10/640 | Sycrest | Norwegia | 3.6.2015 |
EU/1/10/642 | Ibandronsäure Teva | Liechtenstein | 30.6.2015 |
EU/1/10/643 | Rapiscan | Islandia | 12.5.2015 |
EU/1/10/643 | Rapiscan | Liechtenstein | 30.6.2015 |
EU/1/10/643 | Rapiscan | Norwegia | 15.6.2015 |
EU/1/10/646 | VPRIV | Liechtenstein | 30.6.2015 |
EU/1/10/647 | Myclausen | Islandia | 9.6.2015 |
EU/1/10/647 | Myclausen | Liechtenstein | 30.6.2015 |
EU/1/10/647 | Myclausen | Norwegia | 15.6.2015 |
EU/1/10/651 | Clopidogrel HCS | Liechtenstein | 30.6.2015 |
EU/1/10/654 | Leflunomid ratiopharm | Liechtenstein | 30.6.2015 |
EU/1/11/666 | Libertek | Islandia | 12.5.2015 |
EU/1/11/666 | Libertek | Liechtenstein | 30.6.2015 |
EU/1/11/666 | Libertek | Norwegia | 15.5.2015 |
EU/1/11/668 | Daliresp | Islandia | 12.5.2015 |
EU/1/11/668 | Daliresp | Liechtenstein | 30.6.2015 |
EU/1/11/668 | Daliresp | Norwegia | 15.5.2015 |
EU/1/11/749 | Caprelsa | Islandia | 30.1.2015 |
EU/1/11/749 | Caprelsa | Liechtenstein | 28.2.2015 |
EU/1/11/749 | Caprelsa | Norwegia | 29.1.2015 |
EU/1/12/764 | Pixuvri | Islandia | 19.4.2015 |
EU/1/12/764 | Pixuvri | Norwegia | 9.4.2015 |
EU/1/13/818 | Bosulif | Islandia | 11.3.2015 |
EU/1/13/818 | Bosulif | Liechtenstein | 28.2.2015 |
EU/1/13/818 | Bosulif | Norwegia | 6.3.2015 |
EU/1/13/848 | Erivedge | Islandia | 5.6.2015 |
EU/1/13/848 | Erivedge | Liechtenstein | 30.6.2015 |
EU/1/13/848 | Erivedge | Norwegia | 15.6.2015 |
EU/1/13/875 | Deltyba | Islandia | 12.5.2015 |
EU/1/13/875 | Deltyba | Liechtenstein | 30.6.2015 |
EU/1/13/875 | Deltyba | Norwegia | 15.5.2015 |
EU/1/13/890 | Cometriq | Islandia | 5.2.2015 |
EU/1/13/890 | Cometriq | Liechtenstein | 28.2.2015 |
EU/1/13/890 | Cometriq | Norwegia | 13.2.2015 |
EU/1/13/901 | SIRTURO | Islandia | 5.2.2015 |
EU/1/13/901 | Sirturo | Liechtenstein | 28.2.2015 |
EU/1/13/901 | Sirturo | Norwegia | 10.2.2015 |
EU/2/05/055 | Equilis Te | Liechtenstein | 30.6.2015 |
EU/2/05/055 | Equilis Te | Norwegia | 30.6.2015 |
EU/2/09/103 | Respiporc FLU3 | Norwegia | 16.1.2015 |
EU/2/09/104 | Zulvac 8 Ovis | Norwegia | 14.1.2015 |
EU/2/10/106 | Bovilis BTV8 | Islandia | 16.6.2015 |
EU/2/10/106 | Bovilis BTV8 | Liechtenstein | 30.6.2015 |
EU/2/10/106 | Bovilis BTV8 | Norwegia | 26.6.2015 |
EU/2/10/109 | Rhiniseng | Liechtenstein | 30.6.2015 |
ZAŁĄCZNIK III
Wykaz przedłużonych pozwoleń na dopuszczenie do obrotu
Wykaz przedłużonych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data udzielenia zezwolenia |
EU/1/00/133/033-035 | Toujeo | Islandia | 12.5.2015 |
EU/1/00/133/033-035 | Toujeo | Norwegia | 19.5.2015 |
EU/1/01/195/028-029 | Liprolog KwikPen | Islandia | 19.2.2015 |
EU/1/04/303/004 | Orfadin | Islandia | 3.6.2015 |
EU/1/04/303/004 | Orfadin | Norwegia | 28.5.2015 |
EU/1/07/319/009 | Revlimid | Norwegia | 2.3.2015 |
EU/1/07/391/009 | Revlimid | Islandia | 10.3.2015 |
EU/1/08/469/046-049 | Oprymea | Islandia | 2.3.2015 |
EU/1/08/469/050-053 | Oprymea | Islandia | 2.3.2015 |
EU/1/08/469/046-049 | Oprymea | Norwegia | 25.2.2015 |
EU/1/08/469/050-053 | Oprymea | Norwegia | 25.2.2015 |
EU/1/12/771/007-009 | Zoledronic Acid Teva | Islandia | 15.1.2015 |
EU/1/12/798/005-006 | Ibandronic acid Accord | Islandia | 19.4.2015 |
EU/1/12/798/005-006 | Ibandronic acid Accord | Norwegia | 10.4.2015 |
EU/1/13/819/002 | JETREA | Islandia | 13.5.2015 |
EU/1/13/819/002 | Jetrea | Norwegia | 13.5.2015 |
EU/1/96/007/039-042 | Humalog KwikPen | Islandia | 19.2.2015 |
EU/2/06/062/005 | Cerenia | Norwegia | 29.6.2015 |
EU/2/07/078/021 | Rheumocam | Islandia | 4.6.2015 |
EU/2/07/078/021 | Rheumocam | Norwegia | 2.6.2015 |
EU/2/97/004/050-053 | Metacam | Norwegia | 6.5.2015 |
EU/2/97/004/050-053 | Metacam | Islandia | 6.5.2015 |
EU/2/99/014/013-016 | Stronghold | Norwegia | 10.4.2015 |
ZAŁĄCZNIK IV
Wykaz wycofanych pozwoleń na dopuszczenie do obrotu
Wykaz wycofanych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data wycofania |
EU/1/07/426 | Olanzapine Cipla | Norwegia | 21.1.2015 |
EU/1/08/458 | Trevaclyn | Liechtenstein | 28.2.2015 |
EU/1/08/459 | Tredaptive | Liechtenstein | 28.2.2015 |
EU/1/08/460 | Pelzont | Liechtenstein | 28.2.2015 |
EU/1/09/554 | Clopidogrel ratiopharm | Liechtenstein | 28.2.2015 |
EU/1/09/560 | Clopidogrel DURA | Liechtenstein | 30.6.2015 |
EU/1/09/560 | Clopidogrel Dura | Norwegia | 30.6.2015 |
EU/1/10/649 | Clopidogrel Teva Pharma B.V. | Norwegia | 21.1.2015 |
EU/1/10/650 | Clopidogrel Teva Generics B.V. | Islandia | 5.2.2015 |
EU/1/10/664 | Pumarix | Islandia | 20.2.2015 |
EU/1/10/664 | Pumarix | Liechtenstein | 28.2.2015 |
EU/1/10/664 | Pumarix | Norwegia | 31.1.2015 |
EU/1/11/686 | Rasilamlo | Liechtenstein | 30.6.2015 |
EU/1/11/723 | Pioglitazone Krka | Norwegia | 21.1.2015 |
EU/1/11/748 | Docetaxel Mylan (Sunset clause) | Norwegia | 3.2.2015 |
EU/1/12/754 | Sepioglin | Liechtenstein | 28.2.2015 |
EU/1/12/774 | Rienso | Islandia | 12.5.2015 |
EU/1/12/774 | Rienso | Liechtenstein | 30.4.2015 |
EU/1/12/774 | Rienso | Norwegia | 19.5.2015 |
EU/1/12/804 | BindRen | Islandia | 13.3.2015 |
EU/1/12/804 | BindRen | Liechtenstein | 30.4.2015 |
EU/1/12/804 | BindRen | Norwegia | 14.4.2015 |
EU/1/13/867 | Provenge | Liechtenstein | 30.6.2015 |
EU/1/13/867 | Provenge | Norwegia | 15.6.2015 |
EU/1/97/037 | Vistide | Norwegia | 4.2.2015 |
EU/2/04/049 | Purevax RCCh | Islandia | 10.2.2015 |
EU/2/07/071 | SLENTROL | Islandia | 5.2.2015 |
EU/2/07/071 | Slentrol | Liechtenstein | 28.2.2015 |
EU/2/07/071 | Slentrol | Norwegia | 30.3.2015 |
EU/2/11/136 | TruScient | Islandia | 5.2.2015 |
EU/2/11/136 | TruScient | Liechtenstein | 28.2.2015 |
EU/2/11/136 | TruScient | Norwegia | 22.4.2015 |
ZAŁĄCZNIK V
Wykaz zawieszonych pozwoleń na dopuszczenie do obrotu
Wykaz zawieszonych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data zawieszenia |
EU/1/13/847/001 | MACI | Norwegia | 22.1.2015 |
© Unia Europejska, http://eur-lex.europa.eu/
Za autentyczne uważa się wyłącznie dokumenty Unii Europejskiej opublikowane w Dzienniku Urzędowym Unii Europejskiej.